318 related articles for article (PubMed ID: 12637924)
1. Skin cancer is among the most costly of all cancers to treat for the Medicare population.
Housman TS; Feldman SR; Williford PM; Fleischer AB; Goldman ND; Acostamadiedo JM; Chen GJ
J Am Acad Dermatol; 2003 Mar; 48(3):425-9. PubMed ID: 12637924
[TBL] [Abstract][Full Text] [Related]
2. Cost of nonmelanoma skin cancer treatment in the United States.
Chen JG; Fleischer AB; Smith ED; Kancler C; Goldman ND; Williford PM; Feldman SR
Dermatol Surg; 2001 Dec; 27(12):1035-8. PubMed ID: 11849266
[TBL] [Abstract][Full Text] [Related]
3. Incidence Estimate of Nonmelanoma Skin Cancer (Keratinocyte Carcinomas) in the U.S. Population, 2012.
Rogers HW; Weinstock MA; Feldman SR; Coldiron BM
JAMA Dermatol; 2015 Oct; 151(10):1081-6. PubMed ID: 25928283
[TBL] [Abstract][Full Text] [Related]
4. Nonmelanoma skin cancer: an episode of care management approach.
Housman TS; Williford PM; Feldman SR; Teuschler HV; Fleischer AB; Goldman ND; Balkrishnan R; Chen GJ
Dermatol Surg; 2003 Jul; 29(7):700-11. PubMed ID: 12828693
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and economic burden of nonmelanoma skin cancer.
Cakir BÖ; Adamson P; Cingi C
Facial Plast Surg Clin North Am; 2012 Nov; 20(4):419-22. PubMed ID: 23084294
[TBL] [Abstract][Full Text] [Related]
6. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare.
Joseph AK; Mark TL; Mueller C
Dermatol Surg; 2001 Nov; 27(11):955-9. PubMed ID: 11737130
[TBL] [Abstract][Full Text] [Related]
7. Treatment patterns and cost of nonmelanoma skin cancer management.
John Chen G; Yelverton CB; Polisetty SS; Housman TS; Williford PM; Teuschler HV; Feldman SR
Dermatol Surg; 2006 Oct; 32(10):1266-71. PubMed ID: 17034377
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of nonmelanoma skin cancer screening in Crohn's disease patients.
Okafor PN; Stallwood CG; Nguyen L; Sahni D; Wasan SK; Farraye FA; Erim DO
Inflamm Bowel Dis; 2013 Dec; 19(13):2787-95. PubMed ID: 24193153
[TBL] [Abstract][Full Text] [Related]
9. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
10. Skin cancer (Basal cell carcinoma, squamous cell carcinoma, and malignant melanoma): new cases, treatment practice, and health care costs in new brunswick, Canada, 2002-2010.
Pilgrim W; Hayes R; Hanson DW; Zhang B; Boudreau B; Leonfellner S
J Cutan Med Surg; 2014 Oct; 18(5):320-31. PubMed ID: 25186993
[TBL] [Abstract][Full Text] [Related]
11. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark.
Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH
Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376
[TBL] [Abstract][Full Text] [Related]
12. No end in sight: the skin cancer epidemic continues.
Donaldson MR; Coldiron BM
Semin Cutan Med Surg; 2011 Mar; 30(1):3-5. PubMed ID: 21540015
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of a history of skin cancer in 2007: results of an incidence-based model.
Stern RS
Arch Dermatol; 2010 Mar; 146(3):279-82. PubMed ID: 20231498
[TBL] [Abstract][Full Text] [Related]
14. Mohs micrographic surgery vs traditional surgical excision: a cost comparison analysis.
Bialy TL; Whalen J; Veledar E; Lafreniere D; Spiro J; Chartier T; Chen SC
Arch Dermatol; 2004 Jun; 140(6):736-42. PubMed ID: 15210467
[TBL] [Abstract][Full Text] [Related]
15. Impact of topical fluorouracil cream on costs of treating keratinocyte carcinoma (nonmelanoma skin cancer) and actinic keratosis.
Yoon J; Phibbs CS; Chow A; Weinstock MA;
J Am Acad Dermatol; 2018 Sep; 79(3):501-507.e2. PubMed ID: 29505863
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Economic Consequences of Early Cancer After Kidney Transplantation in Contemporary Practice.
Dharnidharka VR; Naik AS; Axelrod D; Schnitzler MA; Xiao H; Brennan DC; Segev DL; Randall H; Chen J; Kasiske B; Lentine KL
Transplantation; 2017 Apr; 101(4):858-866. PubMed ID: 27490413
[TBL] [Abstract][Full Text] [Related]
17. Physician specialty cost differences of treating nonmelanoma skin cancer.
Chirikov VV; Stuart B; Zuckerman IH; Christy MR
Ann Plast Surg; 2015 Jan; 74(1):93-9. PubMed ID: 24503881
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy for nonmelanoma skin cancer: does it have a future?
Urosevic M; Dummer R
Cancer; 2002 Jan; 94(2):477-85. PubMed ID: 11900233
[TBL] [Abstract][Full Text] [Related]
19. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
20. Incidence estimate of nonmelanoma skin cancer in the United States, 2006.
Rogers HW; Weinstock MA; Harris AR; Hinckley MR; Feldman SR; Fleischer AB; Coldiron BM
Arch Dermatol; 2010 Mar; 146(3):283-7. PubMed ID: 20231499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]